Session:   
Updated:   2026-02-04

Home - Bills - Bill - Authors - Dates - Locations - Analyses - Organizations

Measure
Authors Valladares  
Coauthors: Niello  
Subject None
Relating To
Title Relative to Pancreatic Cancer Awareness Month.
Last Action Dt 2025-09-02
State Enrolled
Status Passed
Flags
Vote Req Approp Fiscal Cmte Local Prog Subs Chgs Urgency Tax Levy Active?
None None None None None None None Y
i
Leginfo Link  
Bill Actions
2025-08-29     Read. Adopted. (Ayes 37. Noes 0. Page 2285.)
2025-08-27     From committee: Ordered to third reading.
2025-08-19     Introduced. Referred to Com. on RLS.
Versions
Enrolled     2025-09-02
Introduced     2025-08-19
Analyses TBD
Latest Text Bill Full Text
Latest Text Digest

1.0" ?> 20250SR__006298ENR 98 INTRODUCED 2025-08-19 PASSED_SENATE 2025-08-29 ENROLLED 2025-09-02 2025 0 SR 62 ENR Introduced by Senator Valladares (Coauthor: Senator Niello) LEAD_AUTHOR SENATE Valladares COAUTHOR SENATE Niello Relative to Pancreatic Cancer Awareness Month. Pancreatic Cancer Awareness Month

WHEREAS, In 2025, an estimated 67,440 people will be diagnosed with pancreatic cancer, and 51,980 people will die from the disease in the United States; and

WHEREAS, Pancreatic cancer is one of the deadliest cancers. It is the third leading cause of cancer death in the United States and has a five-year relative survival rate of only 13 percent; and

WHEREAS, Symptoms of pancreatic cancer usually first present themselves in its later stages. If detected at an early stage when surgical removal of a tumor is possible, the five-year survival rate has potentially reached 50 percent, but less than 20 percent of people are diagnosed at this stage. For 52 percent of pancreatic cancer patients where the cancer spreads to a distant part of the body, the five-year survival rate is 3 percent; and

WHEREAS, The federal government invests significantly less money in pancreatic cancer research than it does in research of any other leading deadly cancer. In 2022, the National Cancer Institute (NCI) had a budget of nearly $7,000,000,000. In 2022, only $226,800,000 went towards pancreatic cancer research, which is only 3.3 percent. In 2025, Congress provided $7,220,000,000 for the NCI; and

WHEREAS, The Pancreatic Cancer Action Network (PanCAN) is a national organization that serves the pancreatic cancer community from its California headquarters. The organization is investing $126,000,000 in pancreatic cancer research, including research grants program and clinical initiatives. PanCAN received $15,000,000 in funding from Congress in the 2025 fiscal package; and

WHEREAS, The good health and well-being of the residents of California are enhanced as a direct result of increased awareness about pancreatic cancer and research into early detection, causes, and effective treatments; now, therefore, be it

Resolved by the Senate of the State of California, That the Senate hereby recognizes that, in light of the fact that NCI funding is falling dangerously behind, pancreatic cancer statistics call for aggressive measures now to develop early detection and treatment tools before the incidence dramatically increases; and be it further

Resolved, That the Senate hereby proclaims November 2025 as Pancreatic Cancer Awareness Month in California and urges all Californians to wage hope to end pancreatic cancer; and be it further

Resolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.